Vor Biopharma Statistics Share Statistics Vor Biopharma has 126.68M
shares outstanding. The number of shares has increased by 82.69%
in one year.
Shares Outstanding 126.68M Shares Change (YoY) 82.69% Shares Change (QoQ) 0.09% Owned by Institutions (%) 42.64% Shares Floating 68.23M Failed to Deliver (FTD) Shares 45,341 FTD / Avg. Volume 0.25%
Short Selling Information The latest short interest is 18.41M, so 14.54% of the outstanding
shares have been sold short.
Short Interest 18.41M Short % of Shares Out 14.54% Short % of Float 38.42% Short Ratio (days to cover) 3.47
Valuation Ratios The PE ratio is -0.65 and the forward
PE ratio is -6.66.
Vor Biopharma's PEG ratio is
0.23.
PE Ratio -0.65 Forward PE -6.66 PS Ratio 0 Forward PS 59.6 PB Ratio 0.79 P/FCF Ratio -0.76 PEG Ratio 0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vor Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.19,
with a Debt / Equity ratio of 0.33.
Current Ratio 5.19 Quick Ratio 5.19 Debt / Equity 0.33 Debt / EBITDA -0.28 Debt / FCF -0.32 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-735.31K Employee Count 159 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 115.86% in the
last 52 weeks. The beta is 2.06, so Vor Biopharma's
price volatility has been higher than the market average.
Beta 2.06 52-Week Price Change 115.86% 50-Day Moving Average 2.06 200-Day Moving Average 1.13 Relative Strength Index (RSI) 47.83 Average Volume (20 Days) 18,482,237
Income Statement
Revenue n/a Gross Profit -3.53M Operating Income -121.19M Net Income -116.91M EBITDA -113.39M EBIT -116.91M Earnings Per Share (EPS) -1.7
Full Income Statement Balance Sheet The company has 81.95M in cash and 31.83M in
debt, giving a net cash position of 50.12M.
Cash & Cash Equivalents 81.95M Total Debt 31.83M Net Cash 50.12M Retained Earnings -456.99M Total Assets 205.37M Working Capital 146.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -99.66M
and capital expenditures -229K, giving a free cash flow of -99.89M.
Operating Cash Flow -99.66M Capital Expenditures -229K Free Cash Flow -99.89M FCF Per Share -1.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
